<?xml version="1.0" encoding="UTF-8"?>
<p>In 1997, the world market on medicinal products, not subject to medical prescription was 10 billion dollars, with an annual growth of 6.5% [
 <xref rid="B12" ref-type="bibr">12</xref>]. In 2001 and 2002, about a quarter of the top-selling drugs in the world were from natural products or their derivatives [
 <xref rid="B21" ref-type="bibr">21</xref>]. In 2003, the growth exceeded expectations, achieving sales of over 65 billion dollars, with 9 billion in Europe, with Germany as the European leader [
 <xref rid="B12" ref-type="bibr">12</xref>]. In fact, the use of the rosemary leaf has been approved by the German Commission for dyspepsia, high blood pressure and rheumatism at doses of 4–6 g/day, while the essential oil has been approved at doses of 0.1–1 ml [
 <xref rid="B10" ref-type="bibr">10</xref>]. In 2009, the total market value for PBM was about 83 billion dollars [
 <xref rid="B9" ref-type="bibr">9</xref>].
</p>
